• 1. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Glycosyl compounds
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Study of 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside (CAS: 144985-19-3)

4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside (CAS: 144985-19-3) is a synthetic galactopyranoside derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and glycobiology research. This compound, characterized by its unique structural features, including a methoxyphenyl aglycone and an allyl-protected galactose moiety, has been the subject of recent investigations aimed at exploring its biological activities and synthetic utility.

Recent studies have focused on the synthesis and characterization of 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside, with particular emphasis on its role as a glycosylation donor or intermediate in the preparation of more complex glycoconjugates. Researchers have employed advanced synthetic techniques, such as enzymatic glycosylation and chemoselective allyl deprotection, to optimize the production of this compound. These efforts have led to improved yields and purity, facilitating its use in downstream applications.

In the context of biological activity, preliminary findings suggest that 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside may exhibit modulatory effects on carbohydrate-processing enzymes, including glycosidases and glycosyltransferases. These enzymes play critical roles in various physiological and pathological processes, making them attractive targets for therapeutic intervention. The compound's ability to interact with these enzymes could pave the way for the development of novel inhibitors or probes for studying glycosylation pathways.

Furthermore, the allyl group in 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside offers a versatile handle for further chemical modifications, enabling the synthesis of diverse derivatives with tailored properties. Recent work has explored the use of this compound as a building block for the construction of glycan arrays and other glycoconjugate libraries, which are valuable tools for high-throughput screening and functional studies.

Despite these promising developments, challenges remain in fully elucidating the pharmacological potential of 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside. Future research directions may include in-depth mechanistic studies to understand its interactions with biological targets, as well as in vivo evaluations to assess its therapeutic efficacy and safety profile. Collaborative efforts between synthetic chemists, glycobiologists, and pharmacologists will be essential to unlock the full potential of this compound.

In conclusion, 4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside (CAS: 144985-19-3) represents a promising scaffold in the field of glycochemistry and drug discovery. Its unique structural features and potential biological activities make it a valuable subject for ongoing and future research. Continued advancements in synthetic methodologies and biological evaluations will further enhance our understanding of this compound and its applications in medicine and biotechnology.

• 2871-15-0(PH-ALPA-D-GAL)
• 34246-15-6(D-Glucopyranoside,phenyl)
• 84380-01-8(a-Arbutin)
• 5329-55-5(D-glycero-D-gulo-Heptopyranoside,phenyl, b- (8CI))
• 898826-64-7(Gb3-beta-MP)
• 2818-58-8(Phenyl-β-D-galactopyranoside)
• 497-76-7(Arbutin)
• 3150-20-7(4-Methoxyphenyl b-Galactopyranoside)
• 4630-62-0(Phenyl a-D-Glucopyranoside)
• 6032-32-2(4-Methoxyphenyl β-D-gluocopyranoside)